• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人对氯碘羟喹的经皮吸收

Percutaneous absorption of iodochlorhydroxyquin in humans.

作者信息

Stohs S J, Ezzedeen F W, Anderson A K, Baldwin J N, Makoid M C

出版信息

J Invest Dermatol. 1984 Feb;82(2):195-8. doi: 10.1111/1523-1747.ep12259839.

DOI:10.1111/1523-1747.ep12259839
PMID:6229586
Abstract

Iodochlorhydroxyquin (I) is used in the treatment of diaper rash and other skin disorders, and is presumed to undergo little or no percutaneous absorption. The absorption of (I) from a 3% cream was studied in 5 normal male subjects after a single application of the cream for 12 h. Plasma levels of the drug were followed for 24 h after initial application while urinary excretion was measured for 54 h. (I) was extracted from plasma and urine and assayed by high-performance liquid chromatography. The drug in the range of 0.37-0.56 micrograms/ml was detected in plasma 2 h after application and persisted throughout the treatment period. The mean excretion rate after 12 h of application was 58.4 micrograms/h and the excretion rate was 8.8 micrograms/h at 42 h posttreatment. The elimination rate constant was calculated to be 0.15 h-1. Approximately 40% of the drug was absorbed over the 12-h application period. From the above results it is apparent that significant percutaneous absorption of (I) occurs.

摘要

碘氯羟喹(I)用于治疗尿布疹和其他皮肤疾病,据推测其经皮吸收很少或几乎不发生。在5名正常男性受试者单次涂抹3%乳膏12小时后,研究了(I)从该乳膏中的吸收情况。在初次涂抹后对药物血浆水平进行24小时监测,同时对尿液排泄情况进行54小时测量。从血浆和尿液中提取(I),并通过高效液相色谱法进行测定。涂抹后2小时在血浆中检测到药物浓度在0.37 - 0.56微克/毫升范围内,且在整个治疗期间一直存在。涂抹12小时后的平均排泄率为58.4微克/小时,治疗后42小时的排泄率为8.8微克/小时。计算得出消除速率常数为0.15小时⁻¹。在12小时的涂抹期间,约40%的药物被吸收。从上述结果明显可见,(I)发生了显著的经皮吸收。

相似文献

1
Percutaneous absorption of iodochlorhydroxyquin in humans.人对氯碘羟喹的经皮吸收
J Invest Dermatol. 1984 Feb;82(2):195-8. doi: 10.1111/1523-1747.ep12259839.
2
Percutaneous absorption and disposition of iodochlorhydroxyquin in dogs.碘氯羟喹在犬体内的经皮吸收与处置
J Pharm Sci. 1984 Oct;73(10):1369-72. doi: 10.1002/jps.2600731011.
3
Absorption of 8-hydroxyquinolines through the human skin.8-羟基喹啉经人体皮肤的吸收情况。
Acta Derm Venereol. 1978;58(5):407-11.
4
Percutaneous absorption of clioquinol (Vioform).氯碘羟喹(维沃仿)的经皮吸收
Dermatologica. 1979;159(4):295-301. doi: 10.1159/000250618.
5
Metabolism of 14C-iodochlorhydroxyquin in the dog and the rat.14C-氯碘喹啉在犬和大鼠体内的代谢
J Pharmacobiodyn. 1984 Mar;7(3):164-70. doi: 10.1248/bpb1978.7.164.
6
Percutaneous absorption of iodochlorhydroxyquin in humans and dogs.人和犬中氯碘羟喹的经皮吸收。
Pediatrics. 1984 Jun;73(6):880-1.
7
Intestinal absorption and metabolism of clioquinol in the rat.氯碘羟喹在大鼠体内的肠道吸收与代谢
J Pharmacobiodyn. 1983 Nov;6(11):881-7. doi: 10.1248/bpb1978.6.881.
8
Enterohepatic circulation of clioquinol in the rat.氯碘羟喹在大鼠体内的肠肝循环。
J Pharmacobiodyn. 1984 Jun;7(6):420-5. doi: 10.1248/bpb1978.7.420.
9
Absorption of iodochlorhydroxyquin in humans.人对氯碘羟喹的吸收情况。
J Invest Dermatol. 1985 Jan;84(1):79. doi: 10.1111/1523-1747.ep12274860.
10
Analysis of iodochlorhydroxyquin in biological materials by high-performance liquid chromatography.高效液相色谱法分析生物材料中的氯碘羟喹
J Chromatogr. 1983 Aug 12;276(1):121-8. doi: 10.1016/s0378-4347(00)85072-0.

引用本文的文献

1
A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal Androgen-independent Prostate Cancer. Why and How?一种关于使用氯碘羟喹(锌离子载体)和卡麦角林(催乳素多巴胺激动剂)治疗晚期雄激素非依赖性前列腺癌的有效治疗方案提议。原因及方式?
J Clin Res Oncol. 2019;2(1).
2
Diverse clinical compounds alter the quaternary structure and inhibit the activity of an essential enzyme.多种临床化合物改变四级结构并抑制必需酶的活性。
ChemMedChem. 2011 Jun 6;6(6):1067-73. doi: 10.1002/cmdc.201100009. Epub 2011 Apr 19.
3
Allosteric inhibition of human porphobilinogen synthase.
别构抑制人卟胆原合酶。
J Biol Chem. 2009 Dec 18;284(51):35807-17. doi: 10.1074/jbc.M109.026294.
4
An overview of topical antifungal therapy in dermatomycoses. A North American perspective.皮肤真菌病的局部抗真菌治疗概述。北美视角。
Drugs. 1998 May;55(5):645-74. doi: 10.2165/00003495-199855050-00004.